Nothing Special   »   [go: up one dir, main page]

AU2002366040A1 - Novel tetronic acid derivative - Google Patents

Novel tetronic acid derivative

Info

Publication number
AU2002366040A1
AU2002366040A1 AU2002366040A AU2002366040A AU2002366040A1 AU 2002366040 A1 AU2002366040 A1 AU 2002366040A1 AU 2002366040 A AU2002366040 A AU 2002366040A AU 2002366040 A AU2002366040 A AU 2002366040A AU 2002366040 A1 AU2002366040 A1 AU 2002366040A1
Authority
AU
Australia
Prior art keywords
acid derivative
tetronic acid
novel
novel tetronic
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002366040A
Inventor
Hae-Ryong Park
Kazuo Shinya
Akihiro Tomida
Takashi Tsuruo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2002/009279 external-priority patent/WO2003044208A1/en
Application filed by Individual filed Critical Individual
Publication of AU2002366040A1 publication Critical patent/AU2002366040A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002366040A 2001-11-22 2002-11-22 Novel tetronic acid derivative Abandoned AU2002366040A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2001/357114 2001-11-22
JP2001357114 2001-11-22
PCT/JP2002/009279 WO2003044208A1 (en) 2001-11-22 2002-09-11 Novel tetronic acid dervative
AU2002330374 2002-09-11
PCT/JP2002/012237 WO2003044209A1 (en) 2001-11-22 2002-11-22 Novel tetronic acid derivative

Publications (1)

Publication Number Publication Date
AU2002366040A1 true AU2002366040A1 (en) 2003-06-10

Family

ID=26345148

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002366040A Abandoned AU2002366040A1 (en) 2001-11-22 2002-11-22 Novel tetronic acid derivative

Country Status (2)

Country Link
AU (1) AU2002366040A1 (en)
WO (1) WO2003044209A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006101073A1 (en) * 2005-03-22 2006-09-28 National Institute Of Advanced Industrial Science And Technology Anti-cancer agent and bacterium capable of producing novel compound prunustatin
US20090124562A1 (en) 2005-07-01 2009-05-14 Toudai Tlo, Ltd. Versipelostatin derivative, anti-cancer agent and processes for production of the derivative and agent

Also Published As

Publication number Publication date
WO2003044209A1 (en) 2003-05-30

Similar Documents

Publication Publication Date Title
AU2002360508A1 (en) Substituted hydroxyethylamines
AU2002253999A1 (en) Ascorbic acid analogs for metalloradiopharmaceuticals
AU2001290075A1 (en) Novel alkanoic acid derivatives
AU2002359165A1 (en) Novel compounds
AU2002359320A1 (en) Novel anit-infectives
AU2002251024A1 (en) Substituted fluoroalcoxyphenylsulfonylurea
AU2002321215A1 (en) Substituted 4-aminocyclohexanols
AU2002350942A1 (en) Imidazolidineacetic acid derivatives
AU2002363600A1 (en) Novel phenyl-propargylether derivatives
AU2002329931A1 (en) Salvianolic acid b
AU2002366040A1 (en) Novel tetronic acid derivative
AU2003235429A1 (en) (2s)-2-ethylphenylpropionic acid derivative
AU2001228527A1 (en) Oxazolethoxyphenylpropanoic acid derivative as niddm- medicament
EP1462526A4 (en) Novel tetronic acid derivative
AU2002361450A1 (en) Novel pharmaceutical
AU2001228836A1 (en) Novel difluoroprostaglandin derivative
AU2002244978A1 (en) Alpha-substituted omega-arylfatty acid derivative
AU2001285801A1 (en) 3-arylsulfonyl-2-hydroxy-2-methylpropanoic acid derivates
AU2002335529A1 (en) Novel carbamoylpyrrolidone derivative
AU2002311321A1 (en) Novel norstatin derivative
AU2002331948A1 (en) Protein production
AU2002238545A1 (en) Novel substituted imidazotriazinones
AU2002318741A1 (en) Carboxylic acid derivatives
AU2002254880A1 (en) Novel heteroaryl-diazabicyclo-alkanes as cns-modulators
AU2002313234A1 (en) Novel endomorphine derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase